Drugs / DP-R208
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02709187 | Mar → May 2016 | — | Alvogen Korea | Completed | No outcome recorded |
| Phase 1 | NCT02707224 | Jan → Jun 2015 | — | Alvogen Korea | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DP-R208 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02707224 ↗ |